P. Juillerat

发表

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease

P. Juillerat, 2012 .

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.

V. Pittet, F. Froehlich, J. Gonvers, 2009, Journal of Crohn's & colitis.

The ESRP1-GPR137 axis contributes to intestinal pathogenesis

S. Hapfelmeier, K. McCoy, A. Macpherson, 2017, eLife.

The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases.

J. Korzenik, P. Juillerat, A. Kelstrup, 2014, Journal of Crohn's & colitis.

Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

B. Burnand, V. Pittet, J. Vader, 2009, International journal of epidemiology.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management

H. Tilg, J. Langhorst, M. Sans, 2017, Journal of Crohn's & colitis.

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

H. Tilg, T. Karlsen, K. Boberg, 2016, Journal of Crohn's & colitis.

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease

G. Rogler, A. Schoepfer, S. Vavricka, 2016, Inflammatory bowel diseases.

Strategies for the Prevention of Postoperative Recurrence in Crohn's Disease: Results of a Decision Analysis

A. Ananthakrishnan, J. Korzenik, C. Hur, 2011, The American Journal of Gastroenterology.

Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort

G. Rogler, B. Burnand, C. Beglinger, 2010, Alimentary pharmacology & therapeutics.

Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness

G. Rogler, B. Burnand, F. Seibold, 2010, European journal of gastroenterology & hepatology.

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II.

C. O'Morain, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

S1028 Appropriate Maintenance Treatment for Crohn's Disease: Results of a Multidisciplinary International Expert Panel - EPACT II

W. Bemelman, V. Pittet, F. Froehlich, 2009 .

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

F. Seibold, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

W. Bemelman, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

Evaluating Appropriateness of Treatment for Crohn’s Disease: Feasibility of an Explicit Approach

B. Burnand, I. Guessous, V. Pittet, 2007, Digestion.

Appropriate Treatment for Crohn’s Disease: Methodology and Summary Results of a Multidisciplinary International Expert Panel Approach – EPACT

B. Burnand, V. Pittet, F. Froehlich, 2006, Digestion.

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice

Simon F Brunner, C. Sokollik, J. Borovička, 2020, Communications Biology.

The effect of non-medical factors on variations in the performance of colonoscopy among different health care settings

B. Burnand, A. Holly, K. Lamiraud, 2009 .

Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic

C. J. van der Woude, S. Sebastian, A. Shitrit, 2020, Journal of Crohn's & colitis.

Fatigue in inflammatory bowel disease and its impact on daily activities

G. Rogler, S. Vavricka, C. Baumann, 2020, Alimentary pharmacology & therapeutics.

Novel Nonbiologic Therapies for Ulcerative Colitis

J. Korzenik, P. Juillerat, 2014 .

EPACT II: Project and Methods

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland

G. Rogler, S. Brand, S. Vavricka, 2022, Therapeutic advances in gastroenterology.

Prevalence of lnflammatory Bowel Disease in the Canton of Vaud ( Switzerland ) : A population-based cohort study *

J. Bulliard, I. Guessous, V. Pittet, 2014 .

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.

J. Bulliard, I. Guessous, V. Pittet, 2008, Journal of Crohn's & colitis.

Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study

V. Pittet, C. Gabay, A. Finckh, 2015, Inflammatory bowel diseases.

Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease

G. Rogler, A. Macpherson, S. Vavricka, 2019, United European gastroenterology journal.

Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?

P. Juillerat, P. Michetti, R. Ruetsch, 2022, Current research in pharmacology and drug discovery.

Pregnancy and Breastfeeding in Patients with Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Pregnancy and Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.

C. Siegrist, K. Posfay-Barbe, C. Mottet, 2019, The American journal of gastroenterology.

Drug Safety in Crohn’s Disease Therapy

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Drug Safety in the Treatment of Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients

M. Preisig, C. Sokollik, J. Borovička, 2022, Journal of Gastroenterology.

Maintenance of Medically Induced Remission of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Therapy of Mild to Moderate Luminal Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Maintenance of Remission in Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update

S. Brand, C. Mottet, S. Ben-Horin, 2020, Digestion.

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients

M. Preisig, C. Sokollik, J. Borovička, 2022, Journal of Gastroenterology.

Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort

B. Burnand, A. Macpherson, H. Sokol, 2015, Inflammatory bowel diseases.

Quality of life: a potentially useful measure to indicate subclinical flares in Crohn disease

A. Schoepfer, R. von Känel, V. Pittet, 2012, Internal medicine journal.

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

B. Burnand, V. Pittet, F. Froehlich, 2010, Scandinavian journal of gastroenterology.

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.

A. Hart, L. Peyrin-Biroulet, W. Sandborn, 2021, The lancet. Gastroenterology & hepatology.

Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus

G. Rogler, A. Schoepfer, S. Vavricka, 2019, Digestion.

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

G. Rogler, A. Schoepfer, A. Straumann, 2016, Inflammatory bowel diseases.

Maintenance of Surgically Induced Remission of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study

C. Sokollik, J. Borovička, T. Hinterleitner, 2018, Journal of Crohn's & colitis.

Severe and Steroid-Resistant Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort

G. Rogler, A. Schoepfer, A. Straumann, 2018, European journal of gastroenterology & hepatology.

Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up

K. McCoy, A. Macpherson, E. Slack, 2021, Clinical and translational gastroenterology.

Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, Digestive Diseases and Sciences.

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease

G. Rogler, A. Schoepfer, S. Vavricka, 2022, European journal of gastroenterology & hepatology.

Appropriateness of colonoscopy in Europe (EPAGE II) – Iron-deficiency anemia and hematochezia

B. Burnand, O. Moine, V. Pittet, 2009, Endoscopy.

Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know.

G. Rogler, S. Brand, N. Mueller, 2020, Journal of Crohn's & colitis.

Extraintestinal Manifestations of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2005, Digestion.

Vacuum-Sponge Therapy Placed through a Percutaneous Gastrostomy to Treat Spontaneous Duodenal Perforation

P. Juillerat, E. Benz, Y. Borbély, 2022, Case Reports in Gastroenterology.

Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease

C. Siegrist, K. Posfay-Barbe, C. Mottet, 2021, Digestion.

Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations

S. Vavricka, P. Juillerat, B. Sauter, 2020, Digestion.

Extraintestinal Manifestations of Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Infliximab for the Treatment of Disseminated Pyoderma Gangrenosum Associated with Ulcerative Colitis

S. Christen-Zäch, P. Juillerat, P. Michetti, 2007, Dermatology.

The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.

C. J. van der Woude, S. Sebastian, C. Selinger, 2015, Journal of Crohn's & colitis.

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

J. Danesh, M. Daly, J. Stelling, 2020, Nature Communications.

Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More

S. Brand, P. Juillerat, B. Siegmund, 2020, Digestion.

Microbial network disturbances in relapsing refractory Crohn’s disease

J. Stelling, C. Sokollik, J. Borovička, 2019, Nature Medicine.

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice

C. Sokollik, J. Borovička, F. Ris, 2020, Communications Biology.

Severe and Steroid-Resistant Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.

L. Stassen, J. Gisbert, O. Zmora, 2019, Journal of Crohn's & colitis.

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment.

L. Stassen, J. Gisbert, O. Zmora, 2019, Journal of Crohn's & colitis.

Appropriateness of colonoscopy in Europe (EPAGE II) – Chronic diarrhea and known inflammatory bowel disease

B. Burnand, C. Beglinger, V. Pittet, 2009, Endoscopy.

Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)

J. Borovička, A. Schoepfer, A. Straumann, 2018, Inflammatory Intestinal Diseases.

Swiss Delphi study on iron deficiency.

J. Steurer, I. Guessous, D. Betticher, 2019, Swiss medical weekly.

Management of the Elderly Inflammatory Bowel Disease Patient

G. Rogler, A. Schoepfer, P. Hruz, 2020, Digestion.

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients

G. Rogler, A. Macpherson, J. Rossel, 2018, PloS one.

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study

C. Sokollik, J. Borovička, F. Ris, 2023, BMC Gastroenterology.

Upper Gastrointestinal Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn's disease using real world data.

C. S. Sutherland, C. Sokollik, J. Borovička, 2019, Journal of Crohn's & colitis.

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, International journal of epidemiology.

Treatment of Postoperative Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.

G. Rogler, A. Schoepfer, C. Beglinger, 2014, Journal of Crohn's & colitis.

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients

C. Sokollik, J. Borovička, F. Ris, 2021, BMC Gastroenterology.

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

S. Vermeire, P. Higgins, G. D'Haens, 2022, The Lancet.

Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis

G. Rogler, M. Scharl, B. Yilmaz, 2021, Microorganisms.

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study

S. Vermeire, G. D'Haens, J. Lindsay, 2021, Journal of Crohn's & Colitis.

Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements

G. Rogler, F. Seibold, P. Hruz, 2020, United European gastroenterology journal.

Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease

E. F. Cook, S. Schneeweiss, A. Ananthakrishnan, 2012, Alimentary pharmacology & therapeutics.

Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.

A. Schoepfer, A. Straumann, H. Simon, 2021, Gastrointestinal endoscopy.

Position statement on the use of biosimilars in inflammatory bowel disease.

G. Rogler, S. Vavricka, E. Burri, 2019, Swiss medical weekly.

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management

C. Sokollik, N. Beerenwinkel, J. Borovička, 2021, BMC Gastroenterology.

High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.

G. Rogler, S. Vavricka, R. von Känel, 2015, Journal of Crohn's & colitis.

European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.

M. Toruner, A. Hart, M. Ferrante, 2022, Journal of Crohn's & colitis.

Efficacy of induction therapy with calcineurin inhibitors in combination with ustekinumab for acute severe ulcerative colitis.

X. Roblin, P. Juillerat, P. Veyrard, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease

G. Rogler, S. Brand, J. Rossel, 2021 .

Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission.

G. Rogler, R. von Känel, M. Scharl, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Appropriateness of colonoscopy in Europe (EPAGE II) – Functional bowel disorders: pain, constipation and bloating

M. Numans, B. Burnand, M. Delvaux, 2009, Endoscopy.

Appropriateness of colonoscopy in Europe (EPAGE II) – Surveillance after polypectomy and after resection of colorectal cancer

B. Burnand, V. Pittet, F. Froehlich, 2009, Endoscopy.

Appropriateness of colonoscopy in Europe (EPAGE II). Presentation of methodology, general results, and analysis of complications.

B. Burnand, V. Pittet, F. Froehlich, 2009, Endoscopy.

Appropriateness of colonoscopy in Europe (EPAGE II) – Screening for colorectal cancer

B. Burnand, L. Agréus, V. Pittet, 2009, Endoscopy.

Meta-analysis: Diagnostic Performance of Low-Radiation-Dose Coronary Computed Tomography Angiography

H. Alkadhi, P. Juillerat, M. W. V. von Ballmoos, 2011, Annals of Internal Medicine.

Benchmarking microbial DNA enrichment protocols from human intestinal biopsies

B. Yilmaz, P. Juillerat, B. Misselwitz, 2023, Frontiers in Genetics.